logo BDSP

Base documentaire

Fermeture du portail BDSP le 1er juillet 2019. En savoir plus...

  1. A pharmacist-initiated program of intravenous to oral antibiotic conversion.

    Article, Communication - En anglais

    Midyear clinical meeting of the American Society of Health-System Pharmacists. Las Vegas, Nevada (USA), 1995/12/07.

    A prospective program to convert patients from parenteral to oral antibiotics was evaluated over 12 months to determine its pharmacoeconomic impact on antibiotic acquisition and length of hospital stay.

    Physicians of patients meeting predetermined clinical criteria for mild and moderate infections were contacted to discuss potential oral alternative therapy.

    Clinical end points and economic data were followed in 242 patients (200 converted and 42 not converted but meeting criteria).

    No significant differences were noted between the groups with regard to demographic data, infection diagnosis, clinical outcome, or adverse effects.

    The average number of days of therapy for patients converted was 1.53 days shorter than that of patients who were not converted to oral therapy (p<0.003).

    Cost savings for drug acquisition and length of stay were $15,149.24 and $161,071.88, respectively.

    The intervention program appeared to provide a cost-effective conversion from parenteral to oral antimicrobial administration without compromising patient care.

    It is anticipated that expansion of the program to include additional antibiotics will result in even greater cost savings for the institution.

    Mots-clés Pascal : Economie santé, Homme, Pharmacien, Antibiotique, Infection, Chimiothérapie, Etude comparative, Coût global, Prospective, Hospitalisation, Durée, Traitement, Forme orale, Forme parentérale, Forme pharmaceutique, Analyse coût efficacité, Diminution coût

    Mots-clés Pascal anglais : Health economy, Human, Chemist, Antibiotic, Infection, Chemotherapy, Comparative study, Life cycle cost, Prospective, Hospitalization, Duration, Treatment, Oral form, Parenteral form, Dosage form, Cost efficiency analysis, Cost lowering

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0269170

    Code Inist : 002B30A01C. Création : 15/07/1997.

Fermeture du portail BDSP le 1er juillet 2019

Nous avons le regret de vous informer de la fermeture du portail BDSP le 1er juillet 2019. Du 1er janvier au 30 juin 2019, le site et ses services resteront accessibles mais ne seront plus alimentés, ni mis à jour. En savoir plus...